Novadaq in sales and marketing pact with Kinetic

Novadaq Technologies (TSX:NDQ) has signed exclusive multiyear sales and marketing agreements with Kinetic Concepts Inc. and its LifeCell business unit for the commercialization of Novadaq’s SPY system in additional surgical and wound-care applications. Under the accord, KCI will pay Novadaq exclusivity payments consisting of $3 million up front and additional milestone payments. KCI and Novadaq [...]

TearLab to present at Piper Jaffray Healthcare Conference

TearLab (NASDAQ:TEAR; TSX:TLB) CEO Elias Vamvakas will present an update on the company’s business at the 23rd annual Piper Jaffray Healthcare Conference in New York this morning. Mr. Vamvakas’ presentation will be webcast live and archived for at least 30 days on the company’s website at www.tearlab.com under the “Webcasts” tab in the Investors section. [...]

Diamedica forms advisory group for diabetes products

Diamedica (TSX:DMA) has formed a development advisory group for its DM-199 and DM-204 products for the treatment of Type 1 and Type 2 diabetes, consisting of Dr. Joy Cavagnaro, Dr. Patrick Gearing and Larry Johnson. They are industry experts in the areas of pharmacology and toxicology, manufacturing and regulatory affairs. The new group brings together [...]

BioSante issued new LibiGel method of use patent

BioSante Pharmaceuticals (NASDAQ: BPAX) has been granted a new U.S. patent covering the method of use of its LibiGel  testosterone gel for treating female sexual dysfunction (FSD) and hypoactive sexual desire disorder (HSDD). The patent covers methods for treating FSD and HSDD and also includes using a metered dosage device to deliver the defined dose [...]

Alnylam completes enrollment in Phase 2b study of RSV Infection

Alnylam Pharmaceuticals (NASDAQ:ALNY) has completed patient enrollment in its Phase 2b study with ALN-RSV01, an RNAi therapeutic for the treatment of respiratory syncytial virus (RSV) infection. The Phase 2b trial was designed as a multi-center, randomized, double-blind, placebo-controlled study in RSV-infected lung transplant patients. The study is being conducted at 33 lung transplant centers in [...]

Viking’s 3DHD vision system featured at UK conference

Viking Systems’ (OTCBB:VKNG) 3DHD Vision System was featured at the Annual Scientific Meeting of the Association of Laparoscopic Surgeons (ALS) of Great Britain & Ireland in Cardiff, Wales earlier this month. A report entitled, “3D Laparoscopic Surgery – Status & Future,” indicated that both speed and accuracy of specific tasks improved significantly when performed in [...]

Amorfix turnaround builds broad pipeline

What a difference a year makes. In 2010, Amorfix Life Sciences (TSX:AMF) pulled the plug on its lead blood test to detect the human variant of Creutzfeldt-Jakob disease, thereby halving its stock price and prompting a management shakeup. Today, Amorfix has built an innovative, early-stage product pipeline, including diagnostics and therapeutics for neurodegenerative diseases and [...]

Roth adds Synovis to focus list

Roth Capital Partners has added Synovis Life Technologies (NASDAQ:SYNO) to its Med Tech “focus list” after last week’s market volatility brought the stock down about 14% from recent highs. The stock finished last week at $16.48. Analyst Matt Dolan rates Synovis a “buy,” with a 12-month price target of $21. “In volatile market conditions, we [...]

D. Medical issued U.S. patent

D. Medical Industries (NASDAQ, TASE:DMED) has been granted a U.S. patent, entitled “Devices For Continuous Measurement of Glucose in Body Fluid,” which protects innovative technology that allows for the combination of a minimally invasive continuous glucose monitor and an insulin pump on the same “patch.” Among other features, the technology enables the use of a [...]

Dr. Paul Marks joins Cellceutix SAB

Dr. Paul Marks, who served as CEO of Memorial Sloan-Kettering Cancer Center from 1980 to 1999, has joined the Scientific Advisory Board of Cellceutix (OTCBB:CTIX) . He remains president emeritus and a member of the Sloan-Kettering Institute. Dr. Marks’ research in cell biology and cancer genetics has made major contributions toward a new approach to [...]

Next Page »